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ultiprotein complexes are key determinants of Golgi
apparatus structure and its capacity for intracellu-
lar transport and glycoprotein modiﬁcation. Three
complexes that have previously been partially characterized
include (a) the Golgi transport complex (GTC), identiﬁed in
an in vitro membrane transport assay, (b) the ldlCp complex,
identiﬁed in analyses of CHO cell mutants with defects
in Golgi-associated glycosylation reactions, and (c) the
 
mammalian Sec34 complex, identiﬁed by homology to yeast
Sec34p, implicated in vesicular transport. We show that
these three complexes are identical and rename them the
conserved oligomeric Golgi (COG) complex. The COG
M
 
complex  comprises four previously characterized proteins
(Cog1/ldlBp, Cog2/ldlCp, Cog3/Sec34, and Cog5/GTC-90),
three homologues of yeast Sec34/35 complex subunits (Cog4,
-6, and -8), and a previously unidentiﬁed Golgi-associated
protein (Cog7). EM of ldlB and ldlC mutants established that
COG is required for normal Golgi morphology. “Deep etch”
 
EM of puriﬁed COG revealed an 
 
 
 
37-nm-long structure
comprised of two similarly sized globular domains connected
by smaller extensions. Consideration of biochemical and
 
genetic data for mammalian COG and its yeast homologue
suggests a model for the subunit distribution within this com-
plex, which plays critical roles in Golgi structure and function.
 
Introduction
 
The eukaryotic secretory pathway consists of a set of
membrane-bound compartments through which proteins
move in transport vesicles or larger transport intermediates
(Rothman, 1994). Vesicular transport from one compartment
to the next can be divided into four sequential phases: vesicle
budding; movement to the next compartment; association
of the vesicle with the acceptor compartment; and fusion
of vesicle and acceptor membranes (Rothman, 1994;
Mellman and Warren, 2000). For the Golgi apparatus, the
transport structures may be the Golgi cisternae themselves,
as some secretory cargo moves through the Golgi without
exiting the stack in vesicles (Bonfanti et al., 1998; Mir-
onov et al., 2001).
Many Golgi proteins, such as glycosylation enzymes, are
maintained in a nonuniform steady-state distribution through
the cisternae. These proteins must be transported to their sites
of residence and then either be retained there or, if they move
beyond them, retrieved by retrograde vesicular transport
(Harris and Waters, 1996; Martinez-Menarguez et al., 2001).
Thus, all transport steps appear to involve the movement of
small vesicles (either carrying cargo in the anterograde or resi-
dent enzymes in the retrograde direction) between larger
membrane compartments (Pelham and Rothman, 2000).
Studies in yeast and mammalian cells have led to the
identification of several multisubunit peripheral membrane
protein complexes that are thought to be involved in
membrane trafficking and/or compartment function, including
the Sec6/8 (Grindstaff et al., 1998; Guo et al., 1999), the
TRAPP I (Sacher et al., 2001), and the Sec34/35 (VanRheenen
et al., 1998) complexes. The yeast Sec34/35 complex has
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eight subunits (Whyte and Munro, 2001), is localized to the
Golgi apparatus (Spelbrink and Nothwehr, 1999; Kim et al.,
2001), and has been suggested to be involved in anterograde
ER to Golgi (VanRheenen et al., 1998; Kim et al., 2001), ret-
rograde intra-Golgi (Ram et al., 2002), and endosome to
Golgi (Spelbrink and Nothwehr, 1999) traffic. A mammalian
Sec34-containing complex has also been identified and impli-
cated in Golgi protein trafficking (Suvorova et al., 2001).
Another complex, called the Golgi transport complex
(GTC),* was isolated because of its ability to stimulate an in
vitro intra-Golgi transport assay (Walter et al., 1998). It is a
hetero-oligomeric Golgi-localized complex of 
 
 
 
800 kD,
comprising proteins between 70 and 110 kD. The 90-kD
subunit of GTC, GTC-90, was identified and a cDNA en-
coding the protein was cloned.
The ldlCp complex was discovered during the analysis of
low-density lipoprotein receptor (LDLR)–defective CHO
cell mutants, ldlB and ldlC (Krieger et al., 1981; Podos et
al., 1994; Chatterton et al., 1999). The ldlB- and ldlC-null
mutants, which are viable, exhibit defects in multiple Golgi-
associated reactions that result in the abnormal processing of
the LDLR and many other glycoconjugates (Kingsley et al.,
1986). The defects are not due to drastic disruptions in se-
cretion or endocytosis (Kingsley et al., 1986; Reddy and
Krieger, 1989). The ldlCp protein (
 
 
 
80 kD) is a compo-
nent of a large peripheral Golgi complex whose size and
Golgi-association are dependent on ldlBp (
 
 
 
110 kD) (Po-
dos et al., 1994; Chatterton et al., 1999), which suggested
that they are components of the same complex.
Similarities in the sizes, locations, and subunits of the ldlCp
complex and GTC suggested that they might be identical
(Chatterton et al., 1999). We have explored this possibility
through identification of all the subunits of purified GTC and
examination of the physical association of the proteins in tis-
sues and wild-type and mutant cultured cells. We have found
that GTC and the ldlCp complexes are the same, and it ap-
pears to be to the mammalian homologue of the yeast Sec34/
35 complex. This is consistent with the report of Whyte and
Munro (2001; which appeared during the preparation of this
manuscript), which showed that the yeast homologue of
GTC-90, Cod4p, is a subunit of the Sec34/35 complex. We
suggest that this mammalian complex be called conserved oli-
gomeric Golgi (COG) complex, and its subunits be desig-
nated Cog1–8. We have also examined by EM the structure
of the COG complex and the effects of the null mutations in
ldlB (Cog1) and ldlC (Cog2) on Golgi structure.
 
Results
 
Improved COG complex purification
 
We modified the previously described (Walter et al., 1998)
method of COG purification from bovine brain to improve
the yield (Table I) and followed the purification by anti-Cog5
immunoblotting. During the purification, two peaks of Cog5
were resolved by hydroxyapatite chromatography (Fig. 1 A).
Similar complexes were also seen in CHO cell lysates not sub-
 
jected to the multiple purification steps (see Fig. 7 B). We pu-
rified the protein eluting in the second peak because it repre-
sented the larger complex (Fig. 1 B), here defined as COG. It
is not clear if both complexes are present in vivo or if the small
complex was generated during cell/tissue lysis, or if the peak 1
material, which is slightly smaller in size than COG (Fig. 1
B), shares COG components other than Cog5.
SDS-PAGE analysis of the fractions from the final purifica-
tion step (Table I and Fig. 2) indicated that COG is composed
of eight subunits. If one copy of each subunit were present in
the complex, the calculated molecular weight would be 700 kD.
 
Identification of subunits of the mammalian
COG complex
 
Purified COG subunits were excised from the SDS-PAGE
gel individually (Cog1, -2, -6, and -8) or in pairs (Cog3/
 
*Abbreviations used in this paper: COG, conserved oligomeric Golgi;
GTC, Golgi transport complex; HA, hemagglutinin; IB, immunoblot-
ting; IF, immunofluorescence; LDLR, low-density lipoprotein receptor.
Figure 1. Identification of two Cog5-containing protein complexes 
in bovine brain cytosol. (A) Partially purified COG complex from 
bovine brain cytosol was subjected to ceramic hydroxyapatite 
chromatography (see Materials and methods). The eluted fractions 
were separated by 10% SDS-PAGE and either silver stained (top) or 
subjected to immunoblotting with anti-Cog5 antibody (bottom). 
“Load” is the sample before chromatography, and FT3 and FT7 
are representative flow-through fractions; fractions 28–55 were 
collected during elution with a phosphate gradient. The positions of 
molecular weight markers (kD) are shown on the left. Peaks 1 and 2 
represent Cog5-containing proteins eluting in fractions 31 and 33–36, 
respectively. (B) Peak 1 (9% of fraction 31) and peak 2 (2% of the 
pooled fractions 33–36) from the chromatogram shown in A were 
subjected to gel filtration chromatography on a SMART Superose 6 
column followed by 10% SDS-PAGE and immunoblotting with the 
anti-Cog5 antibody. Load is the sample before chromatography. The 
void volume and the elution positions of size standards (thyroglobulin, 
669 kD; catalase, 232 kD) are shown at the top. All samples loaded 
onto gels and immunoblots represent equivalent amounts within a 
chromatogram. 
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Cog5 and Cog4/Cog7) and sequenced by mass spectrome-
try. Eight protein components were identified (Table II
and Fig. 2 B). All except Cog7 (see below) had been previ-
ously suggested to be components of various mammalian
Golgi-associated complexes. The four individually excised
proteins were identified: Cog1 as ldlBp; Cog2 as ldlCp;
and Cog6 and -8 as the homologues of yeast Cod2p and
Dor1p, respectively. One pair, Cog3/Cog5, was identified
as the mammalian Sec34 and GTC-90; the other, Cog4/
Cog7, was found to be the homologue of yeast Cod1p
(Cog4) and a previously unidentified protein (Table II and
Fig. 2 B). The individual bands in the Cog3/Cog5 doublet
were identified as Sec34 and GTC-90 based on immunob-
lotting (unpublished data). The assignments of the bands
 
in the Cog4/Cog7 doublet were based on the predicted
molecular weights of their human homologues and will re-
quire verification. The presence of Cog1, -2, and -3 in ad-
dition to Cog5 in the purified material was confirmed by
immunoblotting partially (Fig. 3) and completely (Fig. 2
A) purified fractions.
Although present in the COG complex, the Cog1, -2, and
-3 subunits were not detected by immunoblotting in the
smaller Cog5-containing complex (Fig. 3, fractions 30–32).
It is noteworthy that during the early stages of develop-
ment of this new purification protocol, we did not in-
clude the hydroxyapatite purification step (unpublished
data). This resulted in the copurification of COG and the
Sec6/8 complex (Hsu et al., 1996), which suggests that
they share many physicochemical characteristics. This
may not have been fortuitous, as it has been proposed that
the COG and the Sec6/8 complexes are related (Whyte
and Munro, 2001).
 
Cog7 is conserved in higher eukaryotes
 
The human Cog7 cDNA (GenBank/EMBL/DDBJ ac-
cession no. XM_041725) encodes a protein of 770 resi-
 
Table I. 
 
COG complex purification protocol
Purification step Total protein Yield of total protein Yield of COG complex
 
a
 
mg % mg
 
Bovine brain 1.5 
 
 
 
 10
 
6
 
  
 
Bovine brain cytosol 40,000.0 100 ND
Ammonium sulfate 10,200 25.5 3.5
Butyl-Sepharose pool 1,080 2.7 2.1
MonoQ pool 43 0.11 0.63
Ceramic hydroxyapatite pool 3.3 0.082 0.28
Superose 6 pool 0.5 1.2 
 
 
 
 10
 
 
 
3
 
ND
MiniQ pool 0.07 1.75 
 
 
 
 10
 
 
 
4
 
0.07
 
a
 
The yield of COG complex was estimated by quantification of anti-Cog5 immunoblots; the values for the steps before the ceramic hydroxyapatite pool are
overestimates of the true yield of COG because of the copurification of a smaller Cog5-containing complex.
Figure 2. MiniQ purification of COG and identification of its 
subunits. (A) Peak 2 from the ceramic hydroxyapatite chromatogram 
in Fig. 1 A was further purified (Table I), and a portion of each fraction 
from the last chromatographic step (MiniQ) was subjected to 7.5% 
SDS-PAGE and silver staining (top; molecular weight markers [kD] 
shown on the left) or 10% SDS-PAGE and immunoblotting (bottom 
four panels) with antibodies to the indicated proteins. To resolve the 
individual bands, the 7.5% SDS-PAGE gel was run until proteins 
smaller than 60 kD ran off the gel. No additional components (or 
contaminants) were detected in the size range below 65 kD (verified 
by 15% SDS-PAGE; unpublished data). The load lane is the sample 
before chromatography. (B) Enlarged view of the lower portion of 
the lane containing fraction 19 in A. The indicated identities of the 
proteins were determined by mass spectrometry, as described in the 
text. The pairs marked by brackets were excised together and 
sequenced as a mixture. The protein marked with an asterisk is 
rabaptin-5, which is not part of the complex (A). The positions of 
molecular weight (kD) markers are shown on the left.
Figure 3. Comparison of the subunit composition of the small and 
large Cog5-containing complexes. Partially purified COG complex 
(purified by ammonium sulfate precipitation, butyl-Sepharose 
chromotography and MonoQ chromatography) was subjected to 
ceramic hydroxyapatite chromatography. Samples of the fractions 
were separated by 10% SDS-PAGE and subjected to immunoblotting 
with antibodies specific to the indicated proteins as described in the 
legend to Fig. 1 A. Labels are as in Fig. 1 A. 
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dues. Analysis of the human genome database (http://
www.ncbi.nlm.nih.gov/genome/guide/human/) shows that
the Cog7 gene is located on the short arm of chromosome
16 and contains 17 exons. The Paircoil algorithm (Berger
et al., 1995) detected a potential coiled-coil domain be-
tween amino acids 70 and 100 of Cog7, however, the
structure remains to be determined. Closely related homo-
logues of Cog7 can be found in numerous vertebrates and
invertebrates and several plants (Table III). However, ho-
mologues in 
 
Caenorhabditis elegans
 
 or 
 
Saccharomyces cere-
visiae
 
 were not found. Thus, Cog7 joins Cog1 and Cog2
in having no obvious homologue in yeast. The functions
of Cog1, -2, and -7 may be performed by other proteins in
lower eukaryotes (see Discussion).
 
Cog1 and Cog7 are Golgi-associated proteins
 
We used immunofluorescence microscopy to locate endog-
enous Cog1 in CHO cells and Cog7 in HeLa cells trans-
fected with an expression vector encoding a hemagglutinin
(HA) epitope–tagged Cog7. Fig. 4 A shows that both Cog1
(top) and Cog7 (bottom) colocalized significantly, but not
completely, with the Golgi marker mannosidase II in a
perinuclear distribution. Similar results have been observed
for Cog2 and Cog5 (Podos et al., 1994; Walter et al.,
1998). Thus, like other COG complex components, Cog1
and Cog7 are Golgi associated.
Fig. 4 B shows double staining experiments in HeLa cells
using antibodies to HA–Cog7 and Cog1, -3, and -5. These
experiments show a high degree of colocalization of these
four proteins, providing further evidence that they are
components of a single complex.
 
Verification of the subunit composition of COG
 
Copurification of proteins provides strong, but not unequiv-
ocal, evidence that the proteins are members of a complex.
Therefore, we performed coimmunoprecipitation experi-
ments. COG from rat liver cytosol was immunoprecipitated
(Fig. 5 A) using an anti-Cog2 antipeptide antibody (Podos
et al., 1994) in the absence (lane 2) or presence (lane 3) of
the immunogenic peptide to block the precipitation and
subjected to SDS-PAGE and immunoblotting with antibod-
ies to COG subunits. All of the COG subunits examined
coprecipitated with Cog2 (lane 2) in an anti-Cog2 antibody-
specific (compare lanes 1 and 2) and immunogenic peptide–
inhibitable (lane 3) fashion. In each precipitation, 
 
 
 
10% or
more of the total cytosolic content of each component (Fig.
5 A, lane 4) was recovered (lane 2). Similar results were ob-
served using an anti-Cog1 monoclonal antibody to precipi-
tate the complex from a partially purified sample of bovine
brain cytosol (Fig. 5 B). As expected, the anti-Cog1 anti-
body did not precipitate Sec8, a component of the Sec6/8
complex (Hsu et al., 1996) (Fig. 5 B). Thus Cog1, -2, -3,
and -5 are present in the same complex, and the GTC, ldlCp,
and Sec34 complexes are the same entity.
 
COG architecture
 
The ultrastructure of purified COG was visualized by quick
freeze/deep etch/rotary shadow EM (Heuser, 1983). The
images in Fig. 6 are 3-D “anaglyphs,” which are best viewed
with red/green stereo glasses (Heuser, 2000). Samples that
were prefixed with glutaraldehyde (Fig. 6, fixed) were com-
pared with unfixed COG (Fig. 6, unfixed); glutaraldehyde
fixation was used to preserve structures that might disassem-
ble on contact with mica (Heuser, 1989). However, images
of fixed samples must be interpreted with caution, as fixa-
tion can introduce structural artifacts due to cross-linking.
Most of the images of the fixed samples and many of the un-
 
Table III. 
 
Pair-wise sequence comparisons of the identities and 
similarities of Cog7 homologues
Human Cog7 
(identity/similarity)
 
Drosophila
 
 Cog7 
(identity/similarity)
 
%%
 
Drosophila
 
 Cog7 27/45
 
 
 
Arabidopsis
 
 Cog7 23/41 23/39
Percent identity and percent similarity were calculated using the GCG
software package (Wisconsin package version 10.2). The GenBank/EMBL/
DDBJ accession nos. for the human 
 
Drosophila melanogaster
 
 and
 
Arabidopsis thaliana
 
 proteins are XP_041725, AAF56975, and BAB09754,
respectively.
Table II. 
 
Summary of COG complex subunits
Subunit
Apparent mol wt 
(bovine)
 
g
 
Calculated mol wt 
(human)
 
g
 
Previously used 
mammalian nomenclature
 
S. cerevisiae
 
 homologue
Protein ORF
 
Cog1 110 109 ldlBp
 
a
 
(Cod3p/Sec36p)
 
f
 
(YGL223c)
 
f
 
Cog2 77 83 ldlCp
 
a
 
(Sec35p)
 
f
 
(YGR120c)
 
f
 
Cog3 93 94 hSec34p
 
b
 
Sec34p/Grd20p YER157w
Cog4 84 89 hCod1p
 
d
 
Cod1p/Sgf1p/Sec38p YPR105c
Cog5 90 92 GTC-90
 
c
 
Cod4p YNL051w
Cog6 67 68 hCod2p
 
d
 
Cod2p/Sec37p YNL041c
Cog7 82 86 None
 
e
 
(Cod5p)
 
f
 
(YGL005c)
 
f
 
Cog8 70 69 hDor1p
 
d
 
Dor1p YML071c
 
a
 
Kingsley and Krieger, 1984.
 
b
 
Suvorova et al., 2001.
 
c
 
Walter et al., 1998.
 
d
 
Whyte and Munro, 2001.
 
e
 
GenBank/EMBL/DDBJ accession no. XP_041725.
 
f
 
Very little or no sequence homology; however, for tentative assignments see text.
 
g
 
In kD. 
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complex (Fig. 6, first four images in fifth row). The Sec6/8
complex appears to have a large globular or brick-shaped
“core” that is surrounded by short extensions (Hsu et al.,
1998). Other molecules suitable for comparison in size and
shape with COG are shown in the bottom panels of Fig. 6
and are described in its legend.
About a third of the images of unfixed COG (Fig. 6, un-
fixed) appeared similar to the fixed samples, whereas the
others appeared somewhat heterogeneous and “splayed.”
The splayed images tended to display two globules con-
nected by disordered globular or rod-like connections. The
splayed forms ranged up to 50–75 nm long. The overall size
of this form was similar to that of a clathrin triskelion (Fig.
6, fourth image in row 5; Heuser and Kirchhausen, 1985).
Presumably, such splayed forms represent COG complexes
partially disassembled by adhesion with mica. Nevertheless,
they illustrate that native COG seems to be a group of glob-
ular domains interconnected by flexible arms. Additional
studies will be required to determine if the native COG
within cells is a tightly compacted, bilobed, or a relatively
splayed structure.
 
Effects of COG mutations on its composition and size 
and on the structure of the Golgi apparatus
 
The Cog1 and Cog2 proteins were initially identified
during the analysis of two classes of CHO cell mutants,
ldlB and ldlC (Krieger et al., 1981; Kingsley et al., 1986;
Podos et al., 1994; Chatterton et al., 1999). We used im-
munoblotting of whole cell lysates to determine the
steady-state levels of COG subunits in wild-type and mu-
Figure 4. Immunofluorescence localization of Cog1 and Cog7. 
(A) CHO cells (top) or HeLa cells expressing HA epitope–tagged 
Cog7 (bottom) were fixed and double stained with primary antibodies 
to Cog1 or the HA epitope tag (HA–Cog7; center) and mannosidase II 
(Man II; left) and secondary antibodies labeled with either Alexa
®488 
(green)/Alexa
®568 (red; top) or Alexa
®488 (green)/Alexa
®546 (red; 
bottom). Confocal microscopic images were collected and are 
displayed either as a field representing the distribution of a single 
antibody (left and center) or as the merged images (right). Bars, 10  m. 
(B) HeLa cells expressing HA epitope–tagged Cog7 were fixed and 
double stained with primary antibodies to the indicated COG 
complex subunits and the HA epitope tag (HA–Cog7) and secondary 
antibodies labeled with either Alexa
®488 (green) or Alexa
®546 (red). 
Images are presented as in A.
 
fixed samples suggest that COG is bilobed. In some images,
the lobes appeared to be interconnected by thin rods and/or
globules. The fixed form was 37 
 
 
 
 4 (
 
n
 
 
 
 
 
 18) nm long.
Thus, COG appears to be slightly larger than the size
marker thyroglobulin (670 kD; Fig. 6, leftmost in bottom
row). The bilobed appearance of COG looks substantially
different than comparable images of the mammalian Sec6/8
Figure 5. Coimmunoprecipitation of COG complex subunits. 
(A) Cog2 was immunoprecipitated from rat liver cytosol (lanes 2 
and 3) with an anti-Cog2 antipeptide antibody in the absence (lane 2) 
or presence (lane 3) of the immunogenic peptide. The precipitates 
were fractionated by 6% SDS-PAGE and immunoblotted with the 
indicated antibodies. Lane 4 shows 10% of the starting cytosol 
sample. (B) Bovine brain COG complex, partially purified through 
the MonoQ chromatography step, was immunoprecipitated in the 
absence (lane 1) or presence (lane 2) of anti-Cog1 monoclonal 
antibody. The precipitates and 2.5% of the starting sample (lane 
3) were fractionated by 6% SDS-PAGE and immunoblotted with 
antibodies to the indicated COG subunit or the Sec8 component 
of the mammalian Sec6/8 complex. 
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tant cells, as well as stable transfectants in which the mu-
tants’ phenotypes were corrected by transfection with ex-
pression vectors encoding either Cog1 (ldlB[
 
COG1
 
]) or
Cog2 (ldlC[
 
COG2
 
]). Fig. 7 A shows that, as previously
described (Podos et al., 1994), Cog2 was not detected in
the ldlC mutant (lane 4), whereas a somewhat greater
than wild-type expression level of Cog2 was observed in
ldlC[
 
COG2
 
] cells. Similar results were obtained for Cog1
expression in wild-type (lane 1), ldlB (lane 2), and
ldlB[
 
COG1
 
] cells (lane 3), as expected from prior studies
(Chatterton et al., 1999). In ldlB cells, the level of Cog5
was significantly lower (lane 2) than in the wild-type
(lane 1) or transfectant (lane 3) controls, but the levels of
Cog3 and Cog2 were not altered. In contrast, the levels in
ldlC cells of Cog1, -3, and -5 were dramatically reduced
(lane 4) compared with wild-type (lane 1) or transfected
(lane 5) controls. The residual level of Cog5 in ldlC
cells (lane 4) was similar to that in ldlB cells (lane 2). The
absence of Cog1 (lane 2) or Cog2 (lane 4) did not alter
the levels of components of two other complexes involved
in secretion, 
 
 
 
-COP and Sec8 (Fig. 7 A). Thus, the ab-
sence of some COG subunits affected the steady-state lev-
els of other COG components, providing genetic evi-
dence for their interactions. The different effects of the
absence of Cog1 and Cog2 on the levels of other COG
subunits suggest that Cog1 and Cog2 play distinct roles
in the organization of the complex.
The absence of one or more subunits in a macromolecular
assembly, such as COG, should alter the size of the residual
complex. We size fractionated wild-type (Fig. 7 B, top), ldlB
(middle), and ldlC (bottom) cytosols and examined the dis-
tribution of the Cog1, -2, -3, and -5 subunits by immuno-
blotting. In wild-type cytosol, Cog1, -2, -3, and -5 comi-
grated (Fig. 7 B, fractions 21 and 22), and we detected a
distinct, smaller complex containing Cog5 but not the other
immunodetectable COG components (fractions 23–26,
compare with Fig. 3, peak 1). In ldlB (Cog1) cytosol, the
other COG subunits were no longer present in the large
complex (Fig. 7 B, fractions 21 and 22; Chatterton et al.,
1999). Rather, their mobilities showed, in addition to the
Cog5 present in the smaller complex (fractions 23–26), that
they were components of an even smaller entity whose size
was much larger than that expected for the individual sub-
units. In the ldlC (Cog2) mutant, where the steady-state lev-
els of total cellular Cog3 and Cog5 were significantly re-
duced (Fig. 7 A), these subunits were no longer found in the
large complex (Fig. 7 B, fractions 21 and 22). These data
support the conclusion that Cog1, -2, -3, and -5 are compo-
nents of one large complex. They also show that in CHO
cells, as was the case for bovine brain cytosol, some Cog5
was present in a distinct complex that was smaller than
COG and did not contain Cog1, -2, and -3. The chromato-
graphic mobility of this smaller Cog5-containing complex
was apparently unperturbed by the absence of Cog1 or Cog2.
The disruptions in the size and composition of COG in
ldlB and ldlC mutants (Fig. 7) are associated with pleiotro-
pic Golgi functional defects (Kingsley et al., 1986; Podos et
al., 1994; Chatterton et al., 1999). Therefore, we examined,
Figure 6. COG complex architecture. These anaglyph stereo images 
are best viewed with red/green stereo glasses (Heuser, 2000). Fixed 
COG (800 kD, 13S) is in the first and second rows. Unfixed COG is 
in the third and fourth rows. Fixed mammalian Sec6/8 complex is 
displayed in the fifth row (Hsu et al., 1998), with F-actin filament in 
the rightmost panel. Other calibration molecules are in the bottom 
row (left to right): thyroglobulin (670 kD, 19S), IgG (150 kD), dynactin 
(1,200 kD; Schafer et al., 1994), clathrin triskelion (630 kD, 7S; 
Heuser and Kirchhausen, 1985), and cytoplasmic dynein (820 kD, 
20S). All panels are 375,000  when viewed as 1-inch squares.
Figure 7. Steady-state levels of COG components and sizes of 
complexes in wild-type CHO, ldlB (Cog1), and ldlC (Cog2) cells. 
(A) Total cell lysates from the indicated wild-type CHO, ldlB, and 
ldlC cells, as well as ldlB and ldlC revertants corrected by transfection 
with the corresponding cDNA expression vectors (ldlB[COG1] and 
ldlC[COG2]) were fractionated by 7% SDS-PAGE and immunoblotted 
with antibodies to the indicated COG subunits or control proteins 
( -COP and Sec8). (B) Cytosols from wild-type CHO (top), ldlB 
(middle), and ldlC (bottom) cells were fractionated by Superose 6 
gel filtration chromatography. Samples of the fractions were 
analyzed by 7% SDS-PAGE and immunoblotted with the indicated 
antibodies. The position of the void volume and the elution positions 
of size standards (thyroglobulin, 669 kD; apoferritin, 440 kD) are 
shown at the top. 
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by transmission EM, the morphology of the Golgi appara-
tus in wild-type CHO, ldlB, and ldlC cells and their cor-
responding phenotypically corrected transfectants (ldlB
[
 
COG
 
1] and ldlC[
 
COG2
 
]). Fig. 8 shows that the Golgi
morphology in both ldlB and ldlC mutants was abnormal.
At least half, and sometimes all, of the identifiable cisternae
were dilated in the mutants. These dilated cisternae were not
seen in control wild-type cells or transfectants, suggesting
that they were related to the functional defects in ldlB and
ldlC mutants. Additional studies will be required to deter-
mine if the dilated cisternae are located predominantly on
the cis or trans sides of the Golgi stack.
 
Discussion
 
The components of the COG complex
 
We characterized the composition, structure, and function
of a mammalian conserved oligomeric Golgi-localized pro-
tein complex, the COG complex. Purification of COG and
identification of its subunits, Cog1–8, showed that some of
its polypeptides are known components of the GTC, the ldlCp
complex, and the Sec34 complex (Table II). Coimmuno-
precipitation experiments showed that COG components
(Cog1, -2, -3, and -5) are physically associated. Further-
more, the steady-state levels of some COG subunits (Cog1,
-2, -3, and -5) were dramatically reduced in ldlB (Cog1) or
ldlC (Cog2) mutants, establishing genetic associations be-
tween them. The loss of Cog1 or Cog2 in the mutants also
led to a reduction in the sizes of the residual complexes. In
addition, seven COG subunits (Cog1–5, -7, and -8) have
been localized to the mammalian Golgi apparatus (Podos et
al., 1994; Walter et al., 1998; Suvorova et al., 2001; Whyte
and Munro, 2001; this study). Finally, independent analyses
of the yeast Sec34/35 complex (Kim et al., 1999, 2001;
VanRheenen et al., 1999; Whyte and Munro, 2001; Ram et
al., 2002) show that it too is a hetero-octameric complex,
and five of its subunits are close homologues of COG sub-
units (Cog3–6 and -8) (Table II). The remaining three sub-
units in the COG and Sec34/35 complex are also likely to
be related functionally. Indeed, yeast Sec35p and Cog2 have
limited sequence similarity (Whyte and Munro, 2001).
 
The structure of COG
 
Quick freeze/deep etch/rotary shadow EM suggests that
COG, at least after fixation with glutaraldehyde, is 
 
 
 
37 nm
long and divided into two almost equally sized lobes (des-
ignated A and B, see below). In unfixed specimens, we
observed similar bilobed structures and, more frequently,
splayed structures with multiple small globular domains
connected by relatively flexible extensions (Fig. 6).
Insight into the relationship between the bilobed structure
of COG and its subunit composition can be deduced from
our studies in combination with studies of the yeast Sec34/
35 complex (Fig. 9). During the COG purification, we
noted that Cog5 was present both in COG (Fig. 1, peak 2)
and in a smaller complex (Fig. 1, peak 1). The smaller com-
plex may represent a fragment of the COG complex (Fig. 9,
lobe B; see below), contain COG subunits in addition to
Cog5 (see below), and thus correspond to one of the two
lobes seen in the EM images. Because Cog1, -2, and -3 are
Figure 8. Ultrastructure of the Golgi apparatus in 
wild-type, mutant, and revertant cells. Monolayers 
of cells were fixed in situ and epon embedded. 
Thin epon sections (40–50 nm) were viewed by 
transmission EM as described in the Materials and 
methods. Juxtanuclear regions with Golgi cisternae 
are shown: (A) ldlB, (B) ldlB[COG1] (mutation 
complemented by the corresponding cDNA), 
(C) ldlC, (D) ldlC[COG2], and (E) wild-type CHO. 
N, nucleus. Bars, 200 nm. 
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not part of the Cog5-containing smaller complex, they pre-
sumably reside in the other lobe.
Division of COG into two approximately equal-sized
lobes, each having four subunits, is consistent with the
classification by Whyte and Munro (2001) of the yeast
Sec34/35 complex’s subunits into two groups of four,
based on the severity of their mutant phenotypes. The first
group, characterized by more severe phenotypes, contains
Sec34p, Sec35p, Cod1p, and Cod3p, whereas the other
group, distinguished by weaker phenotypes, comprises
Dor1p, Cod2p, Cod4p, and Cod5p (Whyte and Munro,
2001). We suggest that the stronger and weaker pheno-
types are the result of mutations in subunits residing in dis-
tinct lobes of the complex; mutations in lobe A produce
stronger phenotypes (e.g., sec34), and those in lobe B (e.g.,
cod4) give weaker ones (Fig. 9).
With this assumption we can assign other subunits to the A
and B lobes of COG. The weak phenotype of the cod4 mu-
tant places Cog5/Cod4p in lobe B and consequently Cog1,
-2, and -3, which are in the other lobe, in lobe A (Fig. 9).
Moreover, we propose that the fourth protein in lobe A is
Cog4/Cod1p because of the severe cod1 phenotype (Kim et
al., 2001; Whyte and Munro, 2001; Ram et al., 2002). Fi-
nally, the remaining proteins, Cog6–8, must reside in lobe B
(Fig. 9), consistent with the weaker phenotypes of cod2 and
dor1 mutants (Whyte and Munro, 2001), the yeast counter-
parts of Cog6 and Cog8. The proposed composition of lobe B
is consistent with it potentially representing the smaller Cog5-
containing complex in bovine brain and CHO cell cytosols.
As a consequence of these assignments (Fig. 9 and Table
IV), we suggest that Cog7 in lobe B is functionally analo-
gous to yeast Cod5p. Lastly, we speculate that (a) Cog2 and
yeast Sec35p are functional analogs because of their weak se-
quence similarities and assignments to the A lobes, and (b)
the remaining unpaired subunits, Cog1 and yeast Cod3p in
lobe A, are probably functional analogs. (Fig. 9 and Table
IV). Supporting this, mammalian Cog2 and Cog3, or the
corresponding yeast Sec35p and Sec34p, comigrate at a
smaller size when Cog1/Cod3p mutant cytosol is gel filtered
(Fig. 7; Ram et al., 2002). Further work will be required to
rigorously test this model for COG.
The function of COG
Cog1 and Cog2 were originally identified in a genetic
screen for mutants that block LDLR activity in CHO cells
(Krieger et al., 1981). Analysis of the transport/secretion of
the LDLR and vesicular stomatitis virus (VSV) in ldlB and
ldlC mutants and in a revertant of ldlC cells bearing an
extragenic suppressor of the LDLR-deficient phenotype
(Reddy and Krieger, 1989) strongly suggested that neither
membrane protein transport through the secretory path-
way nor normal endocytic cycling are disrupted pro-
foundly. The pleiotropic defects in Golgi–associated glyco-
sylation reactions in these mutants resulted in abnormally
glycosylated, and consequently unstable, LDLRs. The ldlB
and ldlC cells have essentially identical defects in numer-
ous medial- and trans-Golgi–associated reactions that af-
fect virtually all protein- (N-linked and O-linked) and
lipid-linked glycoconjugates (Kingsley et al., 1986). The
pleiotropic nature of the defects suggested that the muta-
tions might affect the regulation, compartmentalization,
transport, or activity of several different Golgi enzymes
and/or enzyme substrates, or the internal milieu of the
Golgi apparatus. This correlates well with our finding in
this study that Golgi cisternae are dilated in these mutants.
Another COG component, Cog5, was first identified
(Walter et al., 1998) in an in vitro assay that measures glyco-
sylation of a cargo protein as a consequence of a membrane
fusion event (Balch et al., 1984). The assay is dependent on
maintenance of an intraluminal environment that is com-
patible with glycosylation (Hiebsch and Wattenberg, 1992)
and on vesicular transport factors, especially those involved
Figure 9. Schematic representation of the putative bilobed 
subunit organization of the mammalian (large type) and yeast 
(small type) COG complexes.
Table IV. Tentative classification of COG complex subunits into two groups based on biochemical behavior and analogy to yeast 
phenotypic data
Group A Group B
Mammalian; present exclusively 
in the large complex 
(corresponding yeast protein)
Yeast; 
stronger phenotype
Mammalian; present in both 
large and small complexes 
(corresponding yeast protein)
Yeast; 
weaker phenotype
Cog1 (none) cod3 Cog5 (Cod4p) cod4
Cog2 (none) sec35 Cog6 (Cod2p) cod2
Cog3 (Sec34) sec34 Cog7 (none) cod5
Cog4 (Cod1p) cod1 Cog8 (Dor1p) dor1
Assignments are based on protein purification, chromatography, immunoblotting (this study), and yeast phenotypic data (Whyte and Munro, 2001). Yeast
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in membrane docking or fusion (Block et al., 1988; Clary
and Rothman, 1990; Waters et al., 1992; Legesse-Miller et
al., 1998). Although this system was originally thought to
measure anterograde vesicle traffic through the Golgi appa-
ratus (Balch et al., 1984), it has been suggested (Love et al.,
1998) that it may in fact measure retrograde traffic of the
glycosyltransferase to the cargo and, as such, recapitulate
retrograde intra-Golgi traffic. The fact that COG is active
in this in vitro system suggests that it may act in docking
and/or fusion of vesicles within the Golgi apparatus, possi-
bly including retrograde glycosyltransferase-bearing vesi-
cles.
Further insight into COG function can be derived from
studies of its yeast homologue, the Sec34/35 complex.
sec34 and sec35 exhibit slow growth, missorting of proteins
in the secretory/vacuolar system, defective protein secre-
tion, underglycosylation of proteins, accumulation of vesi-
cles, and dilated membranous compartments (Wuestehube
et al., 1996; Kim et al., 2001). Mutations in Sec34/35
complex subunits genetically interact with mutations in
components involved in multiple steps of transport to and
through the Golgi apparatus (VanRheenen et al., 1998;
Kim et al., 1999, 2001; Spelbrink and Nothwehr, 1999;
VanRheenen et al., 1999; Whyte and Munro, 2001; Ram
et al., 2002). Of particular note is the recent observation
that Sec34/35 complex components, which are located
throughout the Golgi apparatus (Kim et al., 2001), show
strong genetic interactions with subunits of the COPI vesi-
cle coat (Kim et al., 2001; Ram et al., 2002), which is
thought to function in retrograde traffic within the Golgi
apparatus and from the Golgi apparatus to the ER (Letour-
neur et al., 1994). This prompted Ram et al. (2002) to
suggest that the Sec34/35 complex may function in retro-
grade intra-Golgi traffic, a possibility we have indepen-
dently considered for mammalian COG. Indeed, it is
known that maintenance of Golgi enzymes requires their
retrograde vesicular transport from distal compartments
(Harris and Waters, 1996; Martinez-Menarguez et al.,
2001). Thus, a defect in intra-Golgi retrograde traffic
could lead to the glycosylation defects seen in mammalian
and yeast COG mutants. Compromised COG activity
might also contribute to an aberrant Golgi structure
through mislocalization of crucial Golgi proteins. In addi-
tion, the compromised biosynthetic trafficking seen in
some yeast Sec34/35 complex mutants (Wuestehube et al.,
1996; Kim et al., 2001) may be a consequence of second-
ary anterograde trafficking defects arising from primary
retrograde trafficking defects (Gaynor and Emr, 1997;
Reilly et al., 2001).
Whyte and Munro (2001) suggested that the yeast Sec34/
35 complex may be evolutionarily and functionally related
to the Sec6/8 complex, also called the exocyst, which has
been proposed to tether transport vesicles to the plasma
membrane (Grindstaff et al., 1998; Guo et al., 1999). We
have found that the mammalian COG and Sec6/8 com-
plexes comigrate during numerous purification steps. Thus,
they share many biochemical and biophysical properties, in-
cluding hydrodynamic size and shape and overall surface
charge/hydrophobicity (this study; unpublished data). Also,
as noted previously (Walter et al., 1998), both complexes
contain eight subunits with very similar molecular weights.
However, their appearances in deep etch EM differ. There-
fore, further work to elucidate the relationship of these com-
plexes is required.
In summary, mammalian COG and its yeast homologue
clearly play important roles in determining the structure and
function of the Golgi apparatus and can influence intracellu-
lar membrane trafficking. However, their precise mechanism
of action remains unknown. This is highlighted by the fact
that the yeast Sec34/35 complex’s subunits exhibit numerous
genetic interactions both with cellular components proposed
to be involved in tethering vesicles to the early Golgi appara-
tus (VanRheenen et al., 1998, 1999; Kim et al., 1999, 2001;
Ram et al., 2002) and with the COPI vesicle coat (Kim et al.,
2001; Ram et al., 2002). Genetic and biochemical studies
raise the possibility that the COG and Sec34/35 complexes
may be directly involved in vesicular membrane transport pro-
cesses (e.g., vesicle budding, targeting, or fusion reactions). Al-
ternatively, COG may indirectly influence trafficking as a
consequence of a direct influence on the structure or activity
of one or more compartments of the Golgi apparatus (e.g.,
potential scaffolding activity).
The characterization of the composition and structure of
COG combined with the analysis of COG mutants provides
a strong foundation for future studies of the function of this
important molecular machine.
Materials and methods
Materials
Antibodies used for immunoblotting (IB) and for immunofluorescence (IF)
and their dilutions were as follows: rabbit polyclonal affinity-purified anti-
Cog5 (anti–GTC-90) (IB, 1:500–1,000; IF, 1:100; Walter et al., 1998),
rabbit polyclonal affinity-purified anti-Cog2 Cpep (anti-ldlCp Cpep) (IB,
1:2,000–3,000; Podos et al., 1994), rabbit polyclonal anti-Cog3 serum
(anti-hSec34) (IB, 1:10,000; Suvorova et al., 2001), affinity-purified rabbit
anti-Cog3 (anti-hSec34) (IB, 1:3,000; IF, 1:3,000; Suvorova et al., 2001),
mouse monoclonal anti-Cog1 (anti-ldlBp) (IB, 1:250–600; IF, 1:100; BD
Biosciences), rabbit polyclonal anti-Cog1 (anti-ldlBp) antiserum (IB, 1:3,000),
affinity-purified rabbit polyclonal anti-Cog1 (anti-ldlBp) (IF, 1:150), mouse
monoclonal anti-Sec8 (IB, 1:2,500; BD Biosciences), mouse monoclonal
anti– -COP (IB, 1:1,000; Sigma-Aldrich), rabbit anti–mannosidase II (IF,
1:2,000; a gift from Kelley Moremen, University of Georgia, Athens, GA),
and mouse monoclonal anti–HA-11 (IF, 1:400; Covance).
Dialysis membranes (mol wt cutoff of 12–14 kD) were from BioDesign
Inc. The ceramic hydroxyapatite column was from Bio-Rad Laboratories,
and all other chromatography materials and secondary antibodies conju-
gated with HRP for immunoblotting and chemiluminescence were ob-
tained from Amersham Pharmacia Biotech. Compactin was a gift from A.
Endo (Tokyo Nodo University, Tokyo, Japan). Newborn calf lipoprotein-
deficient serum (NCLPDS) and LDL were prepared as previously described
(Krieger, 1983). Glutaraldehyde, osmium tetroxide, uranyl acetate, and
eponate were obtained from Ted Pella Inc. All other chemicals were pur-
chased from Sigma-Aldrich, unless otherwise noted.
Purification of COG
All procedures were performed at 4 C. Solutions were buffered with 25 mM
TrisCl, pH 8.0, 1 mM DTT (TD) and contained the indicated amounts of
KCl (e.g., TD   1 M KCl) and glycerol, unless otherwise noted. Bovine
brain cytosol was ammonium sulfate precipitated as previously described
(Waters et al., 1992). After resuspension of the precipitated proteins and ad-
justment of the salt concentration to 1M KCl, the sample was chromato-
graphed on butyl-Sepharose. The COG complex was eluted with TD   10
mM KCl, concentrated, and the concentration of KCl in the TD buffer was
adjusted to 160 mM KCl by dialysis and the addition of salt. The sample
was then applied to a MonoQ HR10/10 column, COG eluted in a KCl gra-
dient and dialyzed overnight against 25 mM Hepes-KOH, pH 7.0, 100 mM
KCl, 10% glycerol. After adding potassium phosphate (KPi) to a final con-414 The Journal of Cell Biology | Volume 157, Number 3, 2002
centration of 5 mM, the dialyzed sample was chromatographed on a ce-
ramic hydroxyapatite column. COG complex was eluted with a KPi gradi-
ent and fractions were immediately dialyzed against TD   100 mM KCl,
10% glycerol in a microdialyzer (GIBCO BRL). The second peak of Cog5
immunoreactivity (Fig. 1 A, peak 2) was then concentrated and loaded onto
a Superose 6 HR10/30 sizing column. Fractions containing COG complex
were pooled and chromatographed on a MiniQ column. An estimated 70
 g of COG complex eluted at  220 mM KCl in the gradient.
Analytical gel filtration of the two different Cog5-containing complexes
(Fig. 1 B) was performed on a Superose 6 3.2/30 column.
Gel filtration chromatography of COG complex in cell lysates from
CHO cell lines (Fig. 7 B) was performed as previously described (Chatter-
ton et al., 1999).
Mass spectrometry
COG complex ( 40  g) was separated on a 1-mm-thick 7.5% SDS-poly-
acrylamide gel. The gel was stained with colloidal Coomassie blue (Invi-
trogen) and destained in water. Four individual bands and two doublets
were excised and subjected to electrospray MS/MS peptide sequencing af-
ter in-gel trypsin digestion and HPLC separation (Yates et al., 1999) at the
Harvard Microchemistry Facility.
Deep etch EM of purified COG complex
To visualize single COG complex particles,  20  g of purified COG com-
plex (Fig. 2 A, fraction 18) was visualized on mica by quick freeze/deep
etch/rotary shadowing microscopy as previously described (Heuser, 1983).
For glutaraldehyde fixation, the 10  g/ml COG solution was mixed with a
small volume of 7% glutaraldehyde and incubated for 30 s before mixing
with a suspension of mica flakes. Final anaglyph 3-D images were gener-
ated as described by Heuser (2000).
Transmission EM of cells
Cells were rapidly rinsed with PBS containing 1 mM MgCl2 and 0.1 mM
CaCl2, fixed with 2% glutaraldehyde in 0.1 M sodium cacodylate-HCl, pH
7.2, for 60 min at 4 C, and postfixed with 2% osmium tetraoxide in 0.1 M so-
dium cacodylate-HCl for 60 min at 4 C. The cells were harvested by scraping
from the plastic dish and centrifugation at 750 g for 5 min to form a small pel-
let. The pellet was then dehydrated in graded alcohol up to 70% and en
block stained with 70% alcoholic uranyl acetate for 30 min at 4 C. The sam-
ples were then processed for epon embedding (Vasile et al., 1983). Thin epon
sections were poststained with uranyl acetate and Reynold’s lead citrate and
viewed with a Philips 400 electron microscope operated at 80 kV.
Immunoprecipitation of the COG complex from rat liver cytosol 
and a partially purified bovine brain COG complex preparation
For immunoprecipitation, 5  g of monoclonal anti-Cog1 antibody was
added to 50  l of partially purified bovine brain COG complex (purified
through the MonoQ step). For immunoprecipitation with affinity-purified
anti-Cog2 antibody, 5  g of antibody with or without antigenic peptide
(see below) was added to 400  g of rat liver cytosol. The samples were ad-
justed to a total of 500  l with PBS with (for anti-Cog1) or without (for anti-
Cog2) 5% (wt/vol) nonfat dried milk and incubated overnight at 4 C. Sub-
sequently, the sample was incubated for 2 h at room temperature with 10
 l of a 50% (vol/vol) slurry of protein A–Sepharose CL-4B in PBS. The
beads were then washed four times with 500  l PBS with (for anti-Cog1) or
without (for anti-Cog2) 5% (wt/vol) nonfat dried milk and once with 500  l
of PBS. Precipitated proteins were eluted in SDS sample buffer and ana-
lyzed by immunoblotting. For anti-Cog2 antigenic peptide competition,
the anti-Cog2 antibody was preincubated for 1 h at room temperature with
10  g of the COOH-terminal antigenic peptide (Cpep; Podos et al., 1994)
in 100  l of PBS before addition to the cytosol.
Preparation of the pHM6-Cog7 expression plasmid
Full length Cog7 cDNA was cloned into the pHM6 vector (Roche) with the
restriction enzymes HindIII and KpnI, resulting in the plasmid pHM6-Cog7
coding for an HA epitope–tagged Cog7.
Mammalian cell culture and transfection
Wild-type CHO, ldlB, ldlC, ldlB[COG1], and ldlC[COG2] cells were
grown at 37 C in plastic culture dishes as previously described (Podos et
al., 1994; Chatterton et al., 1999). Here we have renamed two stably trans-
fected cell lines to conform to the nomenclature introduced in this paper
(ldlBp is Cog1; ldlCp is Cog2) as follows: ldlB[LDLB] cells (Chatterton et
al., 1999) are now called ldlB[COG1] cells and ldlC[LDLC] cells (Podos et
al., 1994) are called ldlC[COG2] cells. HeLa cells for immunofluorescence
were grown in standard medium on coverslips and transfected with the
calcium phosphate method (Ausubel et al., 1995).
Immunofluorescence microscopy
Cells grown on coverslips were processed at room temperature as follows.
Cells were washed once with PBS and fixed by rinsing and incubating for 25
min with 2% paraformaldehyde (EM Sciences) in 0.1 M NaPi, pH 7.2. The
coverslips were then rinsed twice and incubated for 15 min in 0.1 M glycine
in PBS. Cells were then blocked in P-B (0.1% saponin, 1% BSA, 2% normal
goat serum [Chemicon]) for 30 min. The coverslips were washed with PBS
followed by a 5-min treatment with 6 M urea in PBS, four 5-min washes in
PBS, and an additional 45-min incubation in P-B. The treatment with urea
was omitted in the case of double staining with anti–mannosidase II and
anti-HA antibodies. The cells were then incubated for 1 h with primary anti-
bodies and washed with P-B four times for 5 min each. Secondary antibod-
ies (Alexa
®488 goat anti–rabbit IgG [H L] conjugate and Alexa
®546 or Al-
exa
®568 goat anti–mouse IgG [H L] conjugate [Molecular Probes]) diluted
1:750 in P-B were applied for 1 h, and the coverslips were washed with PBS
eight times for 5 min and with water for 5 min. Images were obtained with a
ZEISS LSM 510 laser confocal microscope.
Online supplemental material
For a more detailed description of several methods and the generation of the
anti-Cog1 and anti-Cog2 polyclonal antibodies, see the supplemental mate-
rials located at http://www.jcb.org/cgi/content/full/jcb.200202016/DC1.
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